UB Paderborn / Katalog / Suche / in CDI

Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non–Small Cell Lung Cancer Cells

Neoplasia (New York, N.Y.), 2016-03, Vol.18 (3), p.162-171

2016

Volltextzugriff (PDF)

DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis

Journal of gastroenterology and hepatology, 2020-05, Vol.35 (5), p.885-895

2020

Volltextzugriff (PDF)

Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

Journal of hematology and oncology, 2020-05, Vol.13 (1), p.47-10, Article 47

2020

Volltextzugriff (PDF)

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression

Breast cancer research : BCR, 2018-07, Vol.20 (1), p.74-17, Article 74

2018

Volltextzugriff (PDF)

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Cancer communications (London, England), 2021-11, Vol.41 (11), p.1173-1182

2021

Volltextzugriff (PDF)

Tumor location as a novel high risk parameter for stage II colorectal cancers

PloS one, 2017-06, Vol.12 (6), p.e0179910-e0179910

2017

Volltextzugriff (PDF)

Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma

Scientific reports, 2022-05, Vol.12 (1), p.9053-9053, Article 9053

2022

Volltextzugriff (PDF)

Potent antitumor activity of novel taxoids in anaplastic thyroid cancer

Endocrine, 2022-02, Vol.75 (2), p.465-477

2022

Volltextzugriff (PDF)

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells

Journal of experimental & clinical cancer research, 2021-01, Vol.40 (1), p.14-14, Article 14

2021

Volltextzugriff (PDF)

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920940932-1758835920940932

2020

Volltextzugriff (PDF)

A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920930359-1758835920930359

2020

Volltextzugriff (PDF)

A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression

Liver cancer (Basel ), 2021-09, Vol.10 (5), p.500-509

2021

Volltextzugriff (PDF)

Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer

PloS one, 2016-05, Vol.11 (5), p.e0156617-e0156617

2016

Volltextzugriff (PDF)

The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012

BMC cancer, 2017-11, Vol.17 (1), p.783-783, Article 783

2017

Volltextzugriff (PDF)

A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer

Cancer science, 2014-09, Vol.105 (9), p.1182-1188

2014

Volltextzugriff (PDF)

Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of pancreatic cancer

Journal of the National Cancer Center, 2022-12, Vol.2 (4), p.205-215

2022

Volltextzugriff (PDF)

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study

Cancer medicine (Malden, MA), 2018-09, Vol.7 (9), p.4361-4370

2018

Volltextzugriff (PDF)

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

The lancet oncology, 2020-04, Vol.21 (4), p.571-580

2020

Volltextzugriff (PDF)

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Clinical cancer research, 2021-02, Vol.27 (4), p.1003-1011

2021

Volltextzugriff (PDF)

A Sensitive and Selective Method for Determination of Aesculin in Cortex Fraxini by Liquid Chromatography Quadrupole Time-of-Flight Tandem Mass Spectrometry and Application in Pharmacokinetic Study

Journal of analytical methods in chemistry, 2013-01, Vol.2013, p.432465-6

2013

Volltextzugriff (PDF)

Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling

Chemico-biological interactions, 2019-05, Vol.304, p.1-9

2019

Volltextzugriff (PDF)

HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma

Oncology reports, 2015-10, Vol.34 (4), p.1681-1691

2015

Volltextzugriff (PDF)

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study

The lancet oncology, 2020-11, Vol.21 (11), p.1500-1512

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non–Small Cell Lung Cancer Cells

DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis

Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Tumor location as a novel high risk parameter for stage II colorectal cancers

Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma

Potent antitumor activity of novel taxoids in anaplastic thyroid cancer

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review

A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer

A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression

Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer

The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012

A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer

Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of pancreatic cancer

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

A Sensitive and Selective Method for Determination of Aesculin in Cortex Fraxini by Liquid Chromatography Quadrupole Time-of-Flight Tandem Mass Spectrometry and Application in Pharmacokinetic Study

Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling

HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma

Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study

Suchergebnisse filtern